Stephen V Liu, MD· @StephenVLiu · X·· 2 天前评分45
正文 · 机器翻译
#ESMO26 Dr. Byoung Cho @cbcbc1971 展示了在COCOON研究中，采用1L SC amivantamab + lazertinib治疗EGFR+ NSCLC时，简化皮肤科预防方案对皮肤科AE的减少效果与完整方案相似——这可以减轻治疗负担。lazertinib先导治疗1个周期，效果更好。
85 浏览 · 2 赞 · 2 转发 · 0 回复
会议摘要
2700RO按 Rapid oral 1: NSCLC, metastatic 对上
Improving prevention of moderate to severe dermatologic adverse events in EGFR-mutant advanced NSCLC treated with first-line (1L) subcutaneous (SC) amivantamab + lazertinib: First results from a new COCOON cohort
https://esmocongress.esmo.orgNCT06385080NCT06385080按 - **标题 / Title：** A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer 对上
- **标题 / Title：** A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
https://esmocongress.esmo.orgNCT07276399NCT07276399按 - **标题 / Title：** A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer 对上
- **标题 / Title：** A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
https://esmocongress.esmo.org来源：Stephen V Liu, MD · x.com